ATE88328T1 - Verwendung von efomycinen als leistungsfoerderer bei tieren, efomycine und ihre herstellung. - Google Patents

Verwendung von efomycinen als leistungsfoerderer bei tieren, efomycine und ihre herstellung.

Info

Publication number
ATE88328T1
ATE88328T1 AT86103539T AT86103539T ATE88328T1 AT E88328 T1 ATE88328 T1 AT E88328T1 AT 86103539 T AT86103539 T AT 86103539T AT 86103539 T AT86103539 T AT 86103539T AT E88328 T1 ATE88328 T1 AT E88328T1
Authority
AT
Austria
Prior art keywords
efomycins
animals
production
performance enhancers
enhancers
Prior art date
Application number
AT86103539T
Other languages
English (en)
Inventor
Klaus Frobel
Erwin Bischoff
Hartwig Mueller
Olga Salcher
Jong Anno De
Friedrich Berschauer
Martin Scheer
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6266903&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE88328(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of ATE88328T1 publication Critical patent/ATE88328T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/06—Heterocyclic radicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/807—Poultry or ruminant feed
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Husbandry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Saccharide Compounds (AREA)
AT86103539T 1985-03-30 1986-03-15 Verwendung von efomycinen als leistungsfoerderer bei tieren, efomycine und ihre herstellung. ATE88328T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853511753 DE3511753A1 (de) 1985-03-30 1985-03-30 Verwendung von efomycinen als wachstumsfoerderer, efomycine und ihre herstellung
EP86103539A EP0197360B1 (de) 1985-03-30 1986-03-15 Verwendung von Efomycinen als Leistungsförderer bei Tieren, Efomycine und ihre Herstellung

Publications (1)

Publication Number Publication Date
ATE88328T1 true ATE88328T1 (de) 1993-05-15

Family

ID=6266903

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86103539T ATE88328T1 (de) 1985-03-30 1986-03-15 Verwendung von efomycinen als leistungsfoerderer bei tieren, efomycine und ihre herstellung.

Country Status (15)

Country Link
US (1) US5073369A (de)
EP (1) EP0197360B1 (de)
JP (1) JPS61233695A (de)
KR (1) KR860009033A (de)
AR (1) AR242484A1 (de)
AT (1) ATE88328T1 (de)
AU (1) AU599903B2 (de)
CA (1) CA1306432C (de)
DE (2) DE3511753A1 (de)
DK (1) DK142586A (de)
ES (1) ES8706202A1 (de)
FI (1) FI861345A (de)
GR (1) GR860827B (de)
NZ (1) NZ215643A (de)
ZA (1) ZA862321B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3608175A1 (de) * 1986-03-12 1987-09-17 Bayer Ag Efomycin g, seine herstellung und seine verwendung als leistungsfoerderer bei tieren
DE4019024A1 (de) * 1990-06-14 1991-12-19 Bayer Ag Verwendung der efomycine a, e und g als entzuendungshemmende mittel
US5420106A (en) * 1994-03-22 1995-05-30 Bristol-Myers Squibb Company Method and composition having enhanced alpha-hydroxy acid skin permeation and retention
DE19654073A1 (de) 1996-12-23 1998-06-25 Bayer Ag Verwendung von Efomycinen
CN102344468B (zh) * 2011-07-13 2016-09-21 马丁 一类akt/pkb激酶激动剂的获得及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3076746A (en) * 1959-05-24 1963-02-05 Sankyo Co New antibiotics azalomycin b and f and a process for the production thereof
US4132778A (en) * 1977-05-31 1979-01-02 Eli Lilly And Company Antibiotic A-32887
AR229888A1 (es) * 1982-03-24 1983-12-30 Lilly Co Eli Procedimiento para preparar el complejo antibiotico a41030 y sus factores a,b,c,d,e,f, y g
DE3443681A1 (de) * 1984-11-30 1986-06-05 Bayer Ag, 5090 Leverkusen Organisch-chemische verbindung, mikrobiologische verfahren zu ihrer herstellung sowie ihre verwendung
NZ215917A (en) * 1985-05-02 1989-10-27 Merck & Co Inc 22-oh milbemycin derivatives and parasiticidal compositions

Also Published As

Publication number Publication date
US5073369A (en) 1991-12-17
DK142586D0 (da) 1986-03-26
FI861345A (fi) 1986-10-01
ES553444A0 (es) 1987-06-01
GR860827B (en) 1986-07-25
FI861345A0 (fi) 1986-03-27
EP0197360B1 (de) 1993-04-21
DE3688299D1 (de) 1993-05-27
AU5508586A (en) 1986-10-02
DK142586A (da) 1986-10-01
AR242484A1 (es) 1993-04-30
AU599903B2 (en) 1990-08-02
KR860009033A (ko) 1986-12-19
ZA862321B (en) 1986-11-26
JPS61233695A (ja) 1986-10-17
CA1306432C (en) 1992-08-18
DE3511753A1 (de) 1986-10-02
EP0197360A1 (de) 1986-10-15
NZ215643A (en) 1989-05-29
ES8706202A1 (es) 1987-06-01

Similar Documents

Publication Publication Date Title
DE3854013D1 (de) Verwendung von N,N-Dialkylhydroxylaminen und ihre Herstellung.
ATE89560T1 (de) Makrolid-derivate, ihre herstellung und ihre verwendung.
DE3578418D1 (de) Chinonderivate, ihre herstellung und verwendung.
DE3682654D1 (de) Acylaminosiliciumverbindungen, deren verwendung und herstellung.
ATE195323T1 (de) Anti-lymphotoxin-antikörper, herstellung und verwendung
DE3788584D1 (de) Sulfonylharnstoff-Verbindungen, ihre Herstellung und Verwendung als Herbizide.
DE3768922D1 (de) Anthrapyridon-verbindungen, ihre herstellung und ihre verwendung.
DE3581578D1 (de) Antikoerper, herstellung und verwendung.
DE3777366D1 (de) 2,3-dihydro-cumaron-derivate, ihre herstellung und verwendung.
ATE63110T1 (de) Farblose ketimine, ihre herstellung und ihre verwendung als vernetzungsmittel.
DE3777604D1 (de) Makrolid-verbindungen, ihre herstellung und ihre verwendung.
DE3784602D1 (de) Inonos-derivate, ihre herstellung und verwendung.
DE3774718D1 (de) Benzothiazolylazolidine und ihre herstellung und verwendung.
ATE77371T1 (de) 3-carbonyl-1-aminoalkyl-1h-indole, verwendbar als analgetika und ihre herstellung.
DE3761138D1 (de) Nitratderivate und ihre verwendung als gefaesserweiterer.
DE3483638D1 (de) Zirkon-titan-siliciumdioxid-tergele und ihre verwendung als katalysator-traeger.
DE3676218D1 (de) Trimethylcyclohexen-derivate, ihre herstellung und deren verwendung als duftstoffe.
ATE88328T1 (de) Verwendung von efomycinen als leistungsfoerderer bei tieren, efomycine und ihre herstellung.
DE68908389D1 (de) Amidofluoroverbindungen, ihre herstellung und ihre verwendung.
DE3684612D1 (de) Benzotriazole, ihre herstellung und verwendung.
DE3685743D1 (de) Anthracyclinderivate, ihre verwendung als antitumorsubstanzen und ihre herstellung.
DE68919259D1 (de) N-Phenylimide, ihre Herstellung und Verwendung.
ATE45164T1 (de) Steroido(3,2-c>-pyrazole, als antiandrogene und ihre herstellung.
DE3676632D1 (de) 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thione und ihre verwendung als antidepressiva.
DE3671892D1 (de) (2-cyano-2-arylethyl)-pyridine, ihre herstellung und verwendung als fungizide.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee